Tanke Biosciences Corporation
TNBI · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 93% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -742.4% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -781.1% | – | – | – |
| EPS Diluted | -0.003 | -0.004 | -0.002 | -0.001 |
| % Growth | 33.3% | -69.6% | -130% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |